Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: The Hong Kong Diabetes Registry

Diabetes Care

Volumn 30, Issue 1, 2007, Pages 65-70

  Yang, Xilin ^a   So, Wing Yee ^a   Kong, Alice P S ^a   Ho, Chung Shun ^a   Lam, Christopher W K ^a   Stevens, Richard J ^b,c   Lyu, Ramon R ^d   Yin, Donald D ^d   Cockram, Clive S ^a   Tong, Peter C Y ^a   Wong, Vivian ^e   Chan, Juliana C N ^a,f  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MERCK RESEARCH LABORATORIES   (United States)

^e HOSPITAL AUTHORITY   (Hong Kong)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; FOLLOW UP; HONG KONG; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STROKE;

ASIAN CONTINENTAL ANCESTRY GROUP; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; INCIDENCE; MALE; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 33845994738     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1273     Document Type: Article

References (27)

1. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349:1269-1276, 1997
2. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z, Wu Y: Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China. Part i. Morbidity and mortality monitoring. Circulation 103:462-468, 2001
3. Almdal T, Scharling H, Jensen JS, Vestergaard H: The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 164:1422-1426, 2004
4. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB: Stroke risk profile: adjustment for antihypertensive medication: the Framingham Study. Stroke 25:40-43, 1994
5. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR: UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33:1776-1781, 2002
6. Zhang XF, Attia J, D'Este C, Yu XH, Wu XG: A risk score predicted coronary heart disease and stroke in a Chinese cohort. J Clin Epidemiol 58:951-958, 2005
7. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
8. 7a. Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M, for the DiabCare Monitoring Group of the St. Vincent Declaration Steering Committee: Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: the DiabCare initiative. Diabet Med 10:371-377, 1993
9. Laakso M, Pyorala K: Age of onset and type of diabetes. Diabetes Care 8:114-117, 1985
10. Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, Chan NN, Chan JC: White blood cell count is associated with macroand microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27:216 -222, 2004
11. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685-696, 2004
12. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995-1003, 2002
13. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29 -36, 1982
14. Chambless LE, Diao G: Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med 30:3474-3486, 2006
15. Chambless LE, Heiss G, Shahar E, Earp MJ, Toole J: Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 160:259-269, 2004
16. Harrell F: Regression Modelling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, Spinger-Varlag, 2001
17. Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR: An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48:17-26, 2005
18. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421-426, 2001
19. Yang XL, So WY, Kong AP, Clarke P, Ho CS, Lam CW, Ng MH, Lyu RR, Yin DD, Chow CC, Cockram CS, Tong PC, Chan JC: End-stage renal disease risk equations for Hong Kong Chinese type 2 diabetic patients: Hong Kong Diabetes Registry. Diabetologia 49:2299-2308, 2006
20. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134:629-636, 2001
21. Kong AP, So WY, Szeto CC, Chan NN, Luk A, Ma RC, Ozaki R, Ng VW, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC: Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney Int 69:383-387, 2006
22. International Diabetes Federation: IDF global guideline for type 2 diabetes. Available from http://www.globalnews.idf.org/2005/12/idf_global_guid. html. Accessed 7 August 2006
23. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM: A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 136:565-574, 2002
24. Wong KS, Mok V, Lam WW, Kay R, Tang A, Chan YL, Woo J: Aspirin-associated intracerebral hemorrhage: clinical and radiologic features. Neurology 54:2298-2301, 2000
25. Woo J, Lau EM: Risk factors predisposing to stroke in an elderly Chinese population: a longitudinal study. Neuroepidemiology 9:131-134, 1990
26. Moons KG, Bots ML, Salonen JT, Elwood PC, Freire de Concalves A, Nikitin Y, Sivenius J, Inzitari D, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE: Prediction of stroke in the general population in Europe (EUROSTROKE): is there a role for fibrinogen and electrocardiography? J Epidemiol Community Health 56 (Suppl. 1):i30 -i36, 2002
27. Thomsen TF, McGee D, Davidsen M, Jorgensen T: A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 31:817- 822, 2002